COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review.

Simnani, Faizan Zarreen; Singh, Dibyangshee; Kaur, Ramneet

Simnani, Faizan Zarreen; Singh, Dibyangshee; Kaur, Ramneet.

Afiliación

Simnani FZ; KIIT School of Biotechnology, KIIT University, Bhubaneswar, 751024 India.
Singh D; KIIT School of Biotechnology, KIIT University, Bhubaneswar, 751024 India.
Kaur R; Department of Life Sciences, RIMT University, Ludhiana, Punjab India.

3 Biotech ; 12(1): 15, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34926119

Palabras clave

Covid-19; Neutralizing antibody; Rare side effects; Vaccine platforms; Variants

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: 3 Biotech Año: 2022 Tipo del documento: Article